Track the 에이프로젠바이오로직스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에이프로젠바이오로직스 has recorded 83 insider filings. The latest transaction was reported on 7 July 2026 (Purchase). Among the most active insiders: 에이프로젠. The full history is free.
82
Insider Decl.
n/a
Thresholds
n/a
48 ops.
Buy Volume
n/a
16 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.